Status:

COMPLETED

The ShortCut™ Continued Access Study Protocol

Lead Sponsor:

Pi-cardia

Conditions:

Valve-in-valve Procedures

Aortic Stenosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Continued Access Study of the ShortCut™ device (The ShortCut™ CAS).

Detailed Description

The continued access study will be used to collect additional safety and effectiveness data of the ShortCut™ device for splitting bioprosthetic aortic valve leaflets, and to demonstrate coronary arter...

Eligibility Criteria

Inclusion

  • Patient is planned to undergo a percutaneous valve-in-valve procedure for an approved ViV indication due to a failed bioprosthetic valve.
  • Patient is at risk for TAVR-induced coronary artery ostium obstruction.
  • Written informed consent to participate in the study obtained from the subject or subject's legal representative, according to local regulations, prior to initiation of any study mandated procedure.

Exclusion

  • An excessive aortic valve leaflet Calcium morphology, such as diffuse massive calcification at the targeted leaflet for splitting or anatomy not suitable for the use of the ShortCut™ device, as determined by the CT measurements.
  • Carotid or vertebral artery disease that, in the opinion of the local Heart Team, should be treated; or treatment of carotid stenosis ≤ 1 month prior to index procedure.
  • CVA or TIA ≤ 6 months prior to index procedure.
  • History of a myocardial infarction (MI) ≤ 6 weeks prior to index procedure.
  • Hemodynamic or respiratory instability requiring inotropic support, mechanical ventilation or mechanical heart assistance.
  • LVEF \< 30%.
  • Ongoing severe infection or sepsis.
  • Patient has renal insufficiency or is on chronic dialysis.
  • 8\. Need for emergency surgery for any reason. 9. Life expectancy is less than 1 year.

Key Trial Info

Start Date :

July 3 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 12 2025

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT06211296

Start Date

July 3 2024

End Date

May 12 2025

Last Update

November 17 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Los Robles Regional Medical Center

Thousand Oaks, California, United States, 91360

2

Morristown Medical Center

Morristown, New Jersey, United States, 07960

3

Columbia University Medical Center /NYPH

New York, New York, United States, 10032

4

UPMC Pinnacle

Wormleysburg, Pennsylvania, United States, 17043